logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

US stock unusual movement | Nio (NIO.US) rises nearly 3%, the all-new ES8 is about to be officially launched.

date
17/09/2025
According to the Securities Times app, on Tuesday, NIO (NIO.US) rose nearly 3% to $6.68. According to a message from NIO's official Weibo account, NIO Day 2025 will be officially held on September 20, and the new ES8 will be officially launched. Currently, the new ES8 has begun nationwide delivery.
Latest
3 m ago
The exchange rate of Brazilian real against US dollar has risen by 0.5%, with the spot trading reported at 1 US dollar to 5.29 Brazilian real.
5 m ago
Lilac Company: Lilac does not have editorial control over interviews conducted with independent media agencies.
5 m ago
Lilly Corporation: Lilly does not have editorial control over interviews conducted with independent media organizations.
5 m ago
Company Li Lai: The letter from the US Food and Drug Administration (FDA) to Li Lai involves three interviews conducted by independent media organizations; these interviews are not advertisements.
5 m ago
Lilly Company: The letter from the Food and Drug Administration of the United States to Lilly involves three interviews conducted by independent media organizations; these interviews are not advertisements.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.